258
Participants
Start Date
May 31, 2015
Primary Completion Date
November 30, 2016
Study Completion Date
January 30, 2017
Midazolam®
midazolam (0.05 mg/kg, 30% reduction for patients if age ≥70 or ASA class III-IV; Bukwang Pharm Co., Seoul, Republic of Korea)
"Meperidine (pethidine®)"
Meperidine (50mg. 25mg for patients aged ≥70 years; pethidine HCL, Hana Pharm Co., Seoul, Republic of Korea).
Propofol®
Repeated doses of 10-20 mg propofol are titrated to achieve the target level of sedation.
Dexmedetomidine (Precedex®)
Dexmedetomidine (1μg/kg/h, Precedex; Hospira, Seoul, Republic of Korea) or the same volume of normal saline were administered in the MMD and midazolam-meperidine group
Dankook University College of Medicine, Cheonan
Dankook University
OTHER